Cystic Fibrosis Trial, Recruiting (NCT06512064)

Cystic Fibrosis Trial, Recruiting NCT06512064 Sponsor: Indiana University Condition: Cystic Fibrosis

Printed from Voxsanity (voxsanity.com.au) — NCT06512064 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Cystic Fibrosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged between 8 and 70 years old
People who are able to perform breathing tests called spirometry and oscillometry
People who have given their signed consent to participate (for children, both the child's agreement and a parent or guardian's consent are required)
People who are either in good general health with no major breathing or other serious illnesses (for the healthy comparison group), or people who have been diagnosed by a doctor with asthma, COPD, cystic fibrosis, or another airway condition

Who may not be able to join:

People who are unable or unwilling to complete the AWARE test, spirometry, or oscillometry breathing tests
People who have an illness — either short-term or long-term — that the trial investigators believe could affect lung function and influence the test results (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 21 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Erick Forno, MD MPH, Indiana University

Phone: 317-626-6937

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06512064

Sponsor: Indiana University

Phase: Not Applicable

Status: Recruiting

Condition: Cystic Fibrosis

Trial contact: 317-626-6937

More information: https://clinicaltrials.gov/study/NCT06512064

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged between 8 and 70 years old
People who are able to perform breathing tests called spirometry and oscillometry
People who have given their signed consent to participate (for children, both the child's agreement and a parent or guardian's consent are required)
People who are either in good general health with no major breathing or other serious illnesses (for the healthy comparison group), or people who have been diagnosed by a doctor with asthma, COPD, cystic fibrosis, or another airway condition

Who may not be able to join:

People who are unable or unwilling to complete the AWARE test, spirometry, or oscillometry breathing tests
People who have an illness — either short-term or long-term — that the trial investigators believe could affect lung function and influence the test results (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 21 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Indiana University

Registry

ClinicalTrials.gov

Start date

23 July 2024

Est. completion

1 April 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Accurate and reliable disease diagnosis; Estimation of FEV1; Estimation of FVC; Estimation of FEV1/FVC; Estimation of FEF2575; Estimation of R5; Estimation of R20; Estimation of R5-R20; Estimation of X5; Estimation of AX; Identification of airway changes associated disease exacerbations

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov